Zimmern Ron L, Kroese Mark
Public Health Genetics Unit, Strangeways Research Laboratory, Worts Causeway, Cambridge CB1 8RN, UK.
J Public Health (Oxf). 2007 Sep;29(3):246-50. doi: 10.1093/pubmed/fdm028. Epub 2007 May 24.
Scientific advances in genetics and molecular biology have been very successful in advancing our knowledge of biological mechanisms in health and disease, and in catalysing a variety of technological innovations. The number of genetic tests available has consequently increased exponentially over the last few years. Their development has not been accompanied by processes and systems to evaluate these tests in a proper and formal manner to establish their clinical validity and utility. A framework for the evaluation of genetic tests has been developed. This paper reviews the current practice of genetic test evaluation, highlighting the limitations and future challenges in this area of public health.
遗传学和分子生物学领域的科学进展在增进我们对健康和疾病生物学机制的认识以及推动各种技术创新方面取得了巨大成功。因此,在过去几年中,可用的基因检测数量呈指数级增长。然而,这些检测的开发并未伴随着以适当和正式的方式评估这些检测以确定其临床有效性和实用性的流程和系统。现已制定了一个基因检测评估框架。本文回顾了基因检测评估的当前实践,突出了这一公共卫生领域的局限性和未来挑战。